SCHEMBL25898412

SCHEMBL25898412

COCc1cc(CCC(C)(c2cc(C)c(O)c(COC)c2)c2cc(C)c(O)c(COC)c2)cc(C)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.39
PRKCE Q02156 3/20 0.36
MYLK Q15746 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PRKCG P05129 1/20 0.36
MAPT P10636 1/20 0.36
PRKCA P17252 1/20 0.36
APEX1 P27695 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2C9 P11712 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGS1 P23219 2/20 0.34
PTGS2 P35354 2/20 0.34
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25898413 0.97 PRKCE (0.36) SHBGPRKCEMYLKMEN1ALDH1A1
SCHEMBL25898411 0.92 PRKCE (0.39) PRKCEMYLKMEN1ALDH1A1PRKCG
SCHEMBL25898409 0.85 SHBG (0.57) SHBGALDH1A1CYP2C9CYP1A2CYP2D6
SCHEMBL3686389 0.82 PTGS1 (0.47) SHBGALDH1A1MAPTCYP2C9CYP1A2
SCHEMBL25898410 0.82 SHBG (0.53) SHBGALDH1A1CYP2C9CYP1A2CYP2D6
SCHEMBL25898427 0.81 CYP2C19 (0.51) SHBGMEN1ALDH1A1MAPTKMT2A
SCHEMBL26095915 0.81 PRKCE (0.44) PRKCEMYLKMEN1ALDH1A1PRKCG
SCHEMBL25898418 0.79 CYP2D6 (0.34) CYP2C9CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL25898419 0.79 CYP2D6 (0.34) CYP2C9CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL10455314 0.78 PRKCE (0.40) PRKCEMYLKMEN1ALDH1A1PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234905-A1 NOVEL TRISPHENOL DERIVATIVE HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2023-07-27 US disclosed
US-20230234905-A1 NOVEL TRISPHENOL DERIVATIVE HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234905-A1 NOVEL TRISPHENOL DERIVATIVE TTPA, CDK2AP2, CDKL2 SHBG 131/4885PRKCE 3846/4885MYLK 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.